The company is looking to expand its reach in Europe and building up its backlog.
Stocks
-
-
monkeybusinessimages/iStock via Getty Images AbCellera Biologics (ABCL) is up ~35% in Monday morning trading after announcing top-line phase 2 data for ABCL635, its candidate for moderate-to-severe vasomotor symptoms (hot flashes)…
-
Stocks
U.S. stock futures flat as investors await inflation data, grapple with more Iran uncertainty
U.S. stock-index futures were little changed on Sunday, after new demands from Iran raised fresh doubts about the Strait of Hormuz reopening anytime soon and as investors await key inflation…
-
Stocks
‘My wife and I are both retired’: Do we dip into our $2.3 million fund to pay off our $300,000 mortgage at 2.9%?
“Right now, we’re withdrawing about $100,000 a year from our investments.”
-
Stocks
‘This has been an emotionally difficult time’: My brother has cancer and my father is 94. How do I shoulder this responsibility?
“My father placed his $600,000 Wisconsin home into a revocable trust, naming my brother as beneficiary.”
-
Berkshire Hathaway booked a near $13 billion gain on investments in the latest quarter, and has put $32 billion of its cash pile to work.
-
Oil futures end down week on high note as Strait of Hormuz deal turns more uncertain
-
Two months after he was blocked by the Supreme Court, President Donald Trump has resumed his effort to oust Federal Reserve governor Lisa Cook as part of an effort to…
-
Stocks
My brother asked me to sign as his executor, but wouldn’t let me read the document. Should I have refused?
“I imagine scenarios like this happen more often than people realize.”
-
Stocks
As a woman of color who travels alone, is it a waste of money to visit places with zero diversity?
“I don’t want to spend a bunch of money and have a bad time.”
